Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

The U.S. Food and Drug Administration today approved the first generic version of Actos (pioglitazone hydrochloride) tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in adults with type 2 diabetes.

18 Aug 2012

Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin.

18 Aug 2012

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

17 Aug 2012

Affordable Care Act: an interview with Val J. Halamandaris, President of the National Association for Home Care & Hospice (NAHC)

The intent of the Affordable Care Act (ACA) is to provide all Americans with medical insurance. Thirty-five million additional people will be covered, in part by government premiums and in part by making it easier for them to buy their own insurance.

17 Aug 2012

Technion researchers build pancreatic tissue with insulin-secreting cells to treat diabetes

Technion researchers have built pancreatic tissue with insulin-secreting cells, surrounded by a three-dimensional network of blood vessels. The engineered tissue could pave the way for improved tissue transplants to treat diabetes.

16 Aug 2012

Lucentis receives FDA approval for treatment of diabetic macular edema

The U.S. Food and Drug Administration today approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.

10 Aug 2012

Resistant starch can help improve insulin sensitivity

Ingredion Incorporated, a leading global provider of ingredient solutions, today announced the results of a new independent clinical trial published in the September 2012 issue of the Journal of Clinical Endocrinology & Metabolism.

10 Aug 2012

Manipulating hormone-producing cells in the brain may help control blood sugar levels

Manipulating a group of hormone-producing cells in the brain can control blood sugar levels in the body - a discovery that has dramatic potential for research into weight-loss drugs and diabetes treatment.

10 Aug 2012

Grapes reduce key risk factors for heart disease in men with metabolic syndrome

Consuming grapes may help protect heart health in people with metabolic syndrome, according to new research published in the Journal of Nutrition. Researchers observed a reduction in key risk factors for heart disease in men with metabolic syndrome: reduced blood pressure, improved blood flow and reduced inflammation. Natural components found in grapes, known as polyphenols, are thought to be responsible for these beneficial effects.

10 Aug 2012

Researchers uncover new key player in amplifying stress in early stages of diabetes

At its most fundamental level, diabetes is a disease characterized by stress—microscopic stress that causes inflammation and the loss of insulin production in the pancreas, and system-wide stress due to the loss of that blood-sugar-regulating hormone.

9 Aug 2012

Abacus, SurePoint Medical partner to offer diabetes-care plan for employers

SurePoint Medical, provider of direct-to-consumer healthcare supplies and disease-management services, today announced a strategic partnership with Abacus Employer Health Solutions (Abacus) to offer its SurePoint Wellness diabetes-care plan to companies that use Abacus's Good Health Gateway employee health management program.

9 Aug 2012

About half of adults with type 2 diabetes experience acute and chronic pain

Almost half of adults with type 2 diabetes report acute and chronic pain, and close to one quarter report neuropathy, fatigue, depression, sleep disturbance and physical or emotional disability, according to a study of more than 13,000 adults conducted by researchers at the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA. The researchers also found significant rates of shortness of breath, nausea and constipation.

8 Aug 2012

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.

8 Aug 2012

Orexigen Therapeutics reports net loss of $16.7 million for second quarter 2012

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.

7 Aug 2012

Study suggests race-specific cutoff points for a diabetes diagnostic test

Healthcare providers should take into account differences among racial groups when using hemoglobin A1C levels to diagnose and monitor diabetes, new research from Beth Israel Deaconess Medical Center suggests.

7 Aug 2012

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications.

6 Aug 2012

Ginger muscles in on diabetes

Ginger, the common spice and ancient Asian remedy, could have the power to help manage the high levels of blood sugar which create complications for long-term diabetic patients, a University of Sydney study reports.

2 Aug 2012

Investigational drug shows promise against most severe form of congenital hyperinsulinism

A pilot study in adolescents and adults has found that an investigational drug shows promise as the first potential medical treatment for children with the severest type of congenital hyperinsulinism, a rare but potentially devastating disease in which gene mutations cause insulin levels to become dangerously high.

2 Aug 2012

Obesity and heart disease risk in children: an interview with Joana Kist-van Holthe

'What defines obesity in children' is a very important question, primarily because we need to use one definition in order to be able to compare the prevalence of obesity in different countries. It is also important to have a single definition in order to evaluate whether interventions are successful or not.

31 Jul 2012

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

As liver cancer develops, tumor cells lose the ability to produce and release glucose into the bloodstream, a key function of healthy liver cells for maintaining needed blood-sugar levels.

31 Jul 2012

Blood Sugar News and Research

Further Reading

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

Affordable Care Act: an interview with Val J. Halamandaris, President of the National Association for Home Care & Hospice (NAHC)

Technion researchers build pancreatic tissue with insulin-secreting cells to treat diabetes

Lucentis receives FDA approval for treatment of diabetic macular edema

Resistant starch can help improve insulin sensitivity

Manipulating hormone-producing cells in the brain may help control blood sugar levels

Grapes reduce key risk factors for heart disease in men with metabolic syndrome

Researchers uncover new key player in amplifying stress in early stages of diabetes

Abacus, SurePoint Medical partner to offer diabetes-care plan for employers

About half of adults with type 2 diabetes experience acute and chronic pain

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Orexigen Therapeutics reports net loss of $16.7 million for second quarter 2012

Study suggests race-specific cutoff points for a diabetes diagnostic test

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

Ginger muscles in on diabetes

Investigational drug shows promise against most severe form of congenital hyperinsulinism

Obesity and heart disease risk in children: an interview with Joana Kist-van Holthe

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News